Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Hogy Medical Co ( (JP:3593) ).
Hogy Medical has issued another amendment to its prior statements supporting a tender offer for its shares by TCG2509 Co., following regulatory developments under Japan’s Foreign Exchange and Foreign Trade Act. The change reflects the authorities’ decision to shorten the statutory waiting period for foreign exchange-related review, enabling TCG2509 to begin acquiring Hogy Medical’s common stock from 13 February 2026.
In response to the shortened waiting period, TCG2509 filed an amended tender offer registration statement with the Kanto Local Finance Bureau and extended the tender offer period to 2 March 2026, bringing the total offer duration to 45 business days. The company also updated related disclosure documents to reflect the new timeline, clarifying the revised terms for shareholders considering whether to tender their shares during the extended offer window.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen6857.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. is a Japan-based healthcare company listed on the Tokyo Stock Exchange Prime Market under securities code 3593. The company is involved in the medical sector, operating under oversight from ministries including the Ministry of Economy, Trade and Industry and the Ministry of Health, Labour and Welfare, reflecting its role in regulated healthcare-related businesses.
Average Trading Volume: 170,725
Technical Sentiment Signal: Buy
Current Market Cap: Yen144.2B
Learn more about 3593 stock on TipRanks’ Stock Analysis page.